Stress Test for Substance Addiction
(APSU Trial)
Trial Summary
What is the purpose of this trial?
Purpose: This 5-year R01 study will elucidate the role of maturational change across adolescence in neural connectivity and physiological stress responses in the relationship between anxiety and adverse pathways to substance use (APSU). Participants: Children (N=200) aged 12-14 with symptoms of anxiety and their legal caregiver will be recruited from clinical and community sources. Procedures: Youth participants will complete several questionnaires and interviews, undergo neuroimaging while performing cognitive tasks, and have their heart rate and skin conductance monitored during a mildly stressful task. Caregivers will complete several questionnaires.
Research Team
Aysenil Belger, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Eligibility Criteria
This trial is for children aged 12-14 who show symptoms of anxiety. They must be accompanied by a legal caregiver and are willing to undergo questionnaires, interviews, neuroimaging during cognitive tasks, and physiological monitoring under mild stress.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Trier Social Stress Test
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
RTI International
Collaborator